Gilead Sciences, Inc. (GILD) has a consensus analyst rating of Buy, based on 58 analysts covering the stock. Of those, 37 recommend buying, 20 recommend holding, and 1 recommend selling.
The analyst consensus price target for GILD is $158.71, representing a +13.0% upside from the current price of $140.45. Price targets range from a low of $105.00 to a high of $180.00.
